From Discovery to Cure: Addressing the Challenges of Oncology Drug Discovery

DATE
May 20, 2025
TIME
8:00 a.m. PDT, 11:00 a.m. EDT, 16:00 BST, 17:00 CEST - Duration: 60 Minutes

Overview

Eurofins Discovery image
Oncology therapeutics continue to lead FDA and EMA approvals year over year, with drug discovery services in oncology predicted to have a 15% CAGR this year. Regardless of your tumor type focus, or whether your therapeutic approach involves small molecules, antibody-drug conjugates (ADCs), or immunotherapies, Eurofins Discovery is your partner of choice.

We provide Integrated Drug Discovery solutions to help your journey from idea to IND. With a strong team of scientific experts and program managers, we work with you to design your oncology pathway to seamlessly increase your chance of success. Through this webinar, you’ll learn how we are addressing the challenges of oncology drug discovery and supporting programs with our 12,000+ in vitro assays, key services, and the tools needed to advance both monotherapies and combination approaches in the fight against cancer.

Key Learning Objectives:
  • What are the key challenges in oncology drug discovery and how we are addressing them.
  • How undruggable targets are being prosecuted.
  • How clinical failure can be minimized due to unforeseen adverse events.
  • The technologies and modalities that are transforming oncology drug discovery.
  • How to understand your molecule’s mode of action and biological context prior to clinical testing.

Speakers

Alastair J. King, Ph.D.
Head of Biology,
Eurofins Discovery
Michele Modugno, M.Sc.
Scientific Project Lead (Biology),
Eurofins Discovery
Melissa O'Meara
Forensic Science Consultant,
C&EN Media Group

Registration

*By submitting this form, you agree to receive more information on related products and services from the American Chemical Society and its sponsor via email. You understand that you can withdraw your consent at any time. ACS takes your privacy seriously. For more information, please see the ACS Privacy Policy.
Brought to you by:

© 2025 American Chemical Society, 1155 16th St NW, Washington, DC 20036, USA. View our Privacy Policy